These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9479388

  • 21. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
    Lin G, Lee YR, Liu YC, Wu YG.
    Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
    [Abstract] [Full Text] [Related]

  • 22. [Benzimidazolium derivatives with delocalized charge in the cation group as reversible inhibitors of cholinesterases of different origin].
    Rozengart EV, Girshovich MZ, Basova NE.
    Dokl Akad Nauk; 1997 Jul; 355(1):123-5. PubMed ID: 9333408
    [No Abstract] [Full Text] [Related]

  • 23. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA, Hambardzumyan AA, Mkrtchyan MV, Topuzyan VO, Halebyan GP, Asatryan RS.
    Chem Biol Interact; 2008 Jan 10; 171(1):108-16. PubMed ID: 17980356
    [Abstract] [Full Text] [Related]

  • 24. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
    Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E.
    J Med Chem; 2008 Jul 24; 51(14):4200-12. PubMed ID: 18570368
    [Abstract] [Full Text] [Related]

  • 25. [Anticholinesterase effect of potential organophosphorus synergists of pyrethroids].
    Khrunin AV, Eremina OIu.
    Gig Sanit; 2000 Jul 24; (3):66-70. PubMed ID: 10900804
    [No Abstract] [Full Text] [Related]

  • 26. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1673-84. PubMed ID: 16213467
    [Abstract] [Full Text] [Related]

  • 27. Flow microcalorimetric study of butyrylcholinesterase kinetics and inhibition.
    Debord J, Verneuil B, Bollinger JC, Merle L, Dantoine T.
    Anal Biochem; 2006 Jul 15; 354(2):299-304. PubMed ID: 16725100
    [Abstract] [Full Text] [Related]

  • 28. A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors.
    Thomsen T, Kewitz H, Pleul O.
    Enzyme; 1989 Jul 15; 42(4):219-24. PubMed ID: 2698348
    [Abstract] [Full Text] [Related]

  • 29. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA, Hasan MY, Arafat K, Nurulain SM, Schmitt A.
    J Appl Toxicol; 2005 Jul 15; 25(6):562-7. PubMed ID: 16193528
    [Abstract] [Full Text] [Related]

  • 30. Cholinergic activity of isoquinoline alkaloids from the showy autumn crocus (Colchicum speciosum Stev.).
    Basova NE, Rozengart EV, Suvorov AA.
    Dokl Biochem Biophys; 2006 Jul 15; 406():27-31. PubMed ID: 16584002
    [No Abstract] [Full Text] [Related]

  • 31. A rapid TLC bioautographic method for the detection of acetylcholinesterase and butyrylcholinesterase inhibitors in plants.
    Marston A, Kissling J, Hostettmann K.
    Phytochem Anal; 2002 Jul 15; 13(1):51-4. PubMed ID: 11899607
    [Abstract] [Full Text] [Related]

  • 32. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
    Melchiorre C, Andrisano V, Bolognesi ML, Budriesi R, Cavalli A, Cavrini V, Rosini M, Tumiatti V, Recanatini M.
    J Med Chem; 1998 Oct 22; 41(22):4186-9. PubMed ID: 9784091
    [No Abstract] [Full Text] [Related]

  • 33. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
    Svoboda Z, Kvetina J, Kunesová G, Herink J, Bajgar J, Bartosová L, Zivný P, Palicka V.
    Neuro Endocrinol Lett; 2006 Dec 22; 27 Suppl 2():183-6. PubMed ID: 17159811
    [Abstract] [Full Text] [Related]

  • 34. Half-inhibition concentrations of new cholinesterase inhibitors.
    Zdrazilová P, Stepánková S, Komers K, Ventura K, Cegan A.
    Z Naturforsch C J Biosci; 2004 Dec 22; 59(3-4):293-6. PubMed ID: 15241943
    [Abstract] [Full Text] [Related]

  • 35. Selective inhibition of butyrylcholinesterase in vivo in horses by the feed-through larvacide Equitrol.
    Karanth S, Holbrook T, MacAllister C, Pope CN.
    Regul Toxicol Pharmacol; 2008 Mar 22; 50(2):200-5. PubMed ID: 18166255
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Reaction kinetics of biotinylated organophosphorus toxicant, FP-biotin, with human acetylcholinesterase and human butyrylcholinesterase.
    Schopfer LM, Voelker T, Bartels CF, Thompson CM, Lockridge O.
    Chem Res Toxicol; 2005 Apr 22; 18(4):747-54. PubMed ID: 15833035
    [Abstract] [Full Text] [Related]

  • 38. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
    Cerbai F, Giovannini MG, Melani C, Enz A, Pepeu G.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):142-50. PubMed ID: 17643410
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Multivariate statistical analysis of sensitivity of cholinesterases to reversible inhibitors.
    Perchenok AY, Moralev SN.
    Dokl Biochem Biophys; 2006 Oct 31; 407():68-70. PubMed ID: 16776068
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.